| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |